Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DIVA test discovered to detect Johne's disease in goats
"This will support the use of vaccines as part of MAP control programs" - Professor Cath Rees.

Actiphage can differentiate between vaccinated and infected animals.

A new diagnostic test has shown potential to differentiate between vaccinated and infected animals with Johne's disease.

Previously, vaccination of livestock against Johne's disease, an infectious wasting condition affecting ruminants, has been hindered because there is no diagnostic test that can differentiate between vaccinated animals, and those with the disease (DIVA test). 

Researchers have discovered that the Actiphage blood test can differentiate between goats that are naturally infected with Johne's disease, and those with vaccinations. 

This discovery suggests potential for a vaccination programme to protect ruminants from the usually fatal disease. While previous tests to detect infection in vaccinated goats did not work, Actiphage detects live bacteria in a milk or blood sample. Because of this, the test is not affected by vaccination status. 

Professor Cath Rees, from the University of Nottingham, said: “We have now shown that Actiphage is compatible with a range of different methods for purifying white blood cells, demonstrating the versatility of our test and opening up a number of new applications.”

“This study provides evidence that Actiphage can also be used as a DIVA test, allowing us to differentiate between naturally infected and vaccinated animals; this will support the use of vaccines as part of MAP (Mycobacterium avium subspecies paratuberculosis) control programs.”

 

Image (C) PBD Biotech

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.